bromopyruvate has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Allah, AA; Ahmed, AS; Ahmed, NS; Amer, WH; El Sayed, SM; Hamed, AR; Helmy Nabo, MM; Mahmoud, AG; Mohamed, WG; Seddik, MA | 1 |
| Al Marzabani, MM; Attia, YM; El-Abhar, HS; Shouman, SA | 1 |
| Chung, SP; El Sayed, SM; El-Magd, RM; Fukui, K; Kagami, S; Sakai, T; Shishido, Y; Tran, DH; Watanabe, H; Yorita, K | 1 |
| Cao, X; Cheng, H; Jia, G; Knopp, MV; Sun, D; Wang, B; Wassenaar, PA; Yang, M; Zhang, T | 1 |
1 review(s) available for bromopyruvate and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
Topics: Acetaminophen; Adult; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Glutathione; Glycolysis; Hexokinase; Humans; L-Lactate Dehydrogenase; Lactic Acid; Lung Neoplasms; Male; Melanoma; Necrosis; Neovascularization, Pathologic; Pleural Neoplasms; Prognosis; Pyruvates; Treatment Outcome | 2014 |
3 other study(ies) available for bromopyruvate and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glycolysis; Humans; Mice; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pyruvates; Tamoxifen; Xenograft Model Antitumor Assays | 2015 |
D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Line, Tumor; Chelating Agents; Cisplatin; Citric Acid; Cytarabine; D-Amino-Acid Oxidase; Drug Resistance, Neoplasm; Energy Metabolism; Enzyme Inhibitors; Glioblastoma; Hexokinase; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Mice; Neovascularization, Pathologic; Oxidative Stress; Pyruvates | 2012 |
Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model.
Topics: Animals; Antigens, Polyomavirus Transforming; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Glycolysis; Hexokinase; HSP90 Heat-Shock Proteins; Humans; Insulin; Lactams, Macrocyclic; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Neoplasm Proteins; Neovascularization, Pathologic; Pancreatic Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Pyruvates; Rats; Vascular Endothelial Growth Factor A | 2008 |